Education
About Us
Working with TipRanks
Follow Us
Immunome (IMNM)
NASDAQ:IMNM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 9.04M | $ 14.02M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 9.04M | $ -8.91M | $ -631.00K | $ -755.00K | $ -755.00K |
| Operating Income | $ -305.80M | $ -109.53M | $ -36.90M | $ -25.20M | $ -12.26M |
| EBITDA | $ -151.35M | $ -28.27M | $ -36.27M | $ -23.95M | $ -17.04M |
| Net Income | $ -292.96M | $ -106.81M | $ -37.51M | $ -24.47M | $ -17.12M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 217.30M | $ 138.14M | $ 20.32M | $ 49.23M | $ 39.77M |
| Total Assets | $ 240.24M | $ 148.54M | $ 24.05M | $ 57.92M | $ 44.52M |
| Total Debt | $ 4.83M | $ 1.65M | $ 293.00K | $ 317.00K | $ 613.00K |
| Net Debt | $ -138.52M | $ -97.03M | $ -20.03M | $ -48.91M | $ -39.15M |
| Total Liabilities | $ 59.08M | $ 28.66M | $ 7.39M | $ 9.74M | $ 3.18M |
| Stockholders' Equity | $ 181.16M | $ 119.88M | $ 16.65M | $ 48.19M | $ 41.34M |
| Cash Flow | |||||
| Free Cash Flow | $ -117.97M | $ -8.40M | $ -28.94M | $ -18.30M | $ -12.72M |
| Operating Cash Flow | $ -110.79M | $ -7.57M | $ -28.69M | $ -18.23M | $ -12.13M |
| Investing Cash Flow | $ -85.06M | $ -30.48M | $ -248.00K | $ -79.00K | $ -586.00K |
| Financing Cash Flow | $ 240.53M | $ 116.41M | $ 32.00K | $ 27.77M | $ 49.94M |